Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5714)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2019 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou ML, Chen FS, Mao H. Clinical significance and role of up-regulation of SERPINA3 expression in endometrial cancer. World J Clin Cases 2019; 7(15): 1996-2002 [PMID: 31423431 DOI: 10.12998/wjcc.v7.i15.1996] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i15/1996.htm |
| Number | Citing Articles |
| 1 |
Junshang Dai, Yuwen Pan, Yili Chen, Shuzhong Yao. A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1024508
|
| 2 |
Lanlin Hu, Mingxin Liu, Bo Tang, Xurui Li, Huasheng Xu, Huani Wang, Dandan Wang, Sijia Liu, Chuan Xu. PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3. Cancer Gene Therapy 2024; 31(11): 1696 doi: 10.1038/s41417-024-00829-w
|
| 3 |
Jing Zhou, Mengdi Zhu, Qi Wang, Yiyuan Deng, Nianqiu Liu, Yujie Liu, Qiang Liu. SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-05065-w
|
| 4 |
Qiushi Xu, Bing Yu, Wenjing Chen, Wenlong Li, Yuanhao Sun, Yanchun Fang. CircSERPINA3 promoted cell proliferation, migration, and invasion of laryngeal squamous cell carcinoma by targeting miR‐885‐5p. Cell Biology International 2022; 46(11): 1852 doi: 10.1002/cbin.11872
|
| 5 |
Sheng Peng, Wenjin Liang, Zhongzhong Liu, Shaojun Ye, Zhiyong Peng, Zibiao Zhong, Qifa Ye. Hypothermic machine perfusion reduces donation after circulatory death liver ischemia–reperfusion injury through the SERPINA3-mediated PI3Kδ/Akt pathway. Human Cell 2023; 37(2): 420 doi: 10.1007/s13577-023-01012-3
|
| 6 |
Chiara Bazzichetto, Claudio Luchini, Fabiana Conciatori, Vanja Vaccaro, Ilaria Di Cello, Paola Mattiolo, Italia Falcone, Gianluigi Ferretti, Aldo Scarpa, Francesco Cognetti, Michele Milella. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. International Journal of Molecular Sciences 2020; 21(22): 8841 doi: 10.3390/ijms21228841
|
| 7 |
Anjana Soman, S. Asha Nair. Unfolding the cascade of SERPINA3: Inflammation to cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(5): 188760 doi: 10.1016/j.bbcan.2022.188760
|
| 8 |
Mateusz de Mezer, Anna Markowska, Janina Markowska, Monika Krzyżaniak, Beniamin Oskar Grabarek, Filip Pokusa, Jakub Żurawski. Immunohistochemical Expression of the SERPINA3 Protein in Uterine
Fibroids. Current Pharmaceutical Biotechnology 2024; 25(13): 1758 doi: 10.2174/0113892010264673231111082438
|
| 9 |
Muhammad Mujammami, Mohamed Rafiullah, Khalid Akkour, Assim A. Alfadda, Afshan Masood, Salini Scaria Joy, Hani Alhalal, Maria Arafah, Eman Alshehri, Ibrahim O. Alanazi, Hicham Benabdelkamel. Plasma Proteomic Signature of Endometrial Cancer in Patients with Diabetes. ACS Omega 2024; 9(4): 4721 doi: 10.1021/acsomega.3c07992
|
| 10 |
Yuqing Tian, Jiefu Yang, Ming Lan, Tong Zou. Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure. Aging 2020; 12(24): 26221 doi: 10.18632/aging.202405
|
| 11 |
Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, Michał Chojnicki, Leszek Niepolski, Magdalena Sobieska, Agnieszka Przystańska. SERPINA3: Stimulator or Inhibitor of Pathological Changes. Biomedicines 2023; 11(1): 156 doi: 10.3390/biomedicines11010156
|
| 12 |
Amira M Othman, Noha Abdel-Rahman, May Denewer, Laila A Eissa. Elevated serum ELABELA and SERPINA3 as novel biomarkers to predict poor prognosis in Egyptian chronic lymphocytic leukemia patients. The Egyptian Journal of Haematology 2023; 48(2): 191 doi: 10.4103/ejh.ejh_2_23
|
| 13 |
Hao Zhang, Gui-Yuan Zhang, Wei-Chao Su, Ya-Ting Chen, Yu-Feng Liu, Dong Wei, Yan-Xi Zhang, Qiu-Yi Tang, Yu-Xiang Liu, Shi-Zhi Wang, Wen-Chao Li, Anke Wesselius, Maurice P. Zeegers, Zi-Yu Zhang, Yan-Hong Gu, W. Andy Tao, Evan Yi-Wen Yu. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis. Molecules 2022; 27(23): 8155 doi: 10.3390/molecules27238155
|
| 14 |
Isabelle Gregga, Paul D. P. Pharoah, Simon A. Gayther, Ani Manichaikul, Hae Kyung Im, Siddhartha P. Kar, Joellen M. Schildkraut, Heather E. Wheeler. Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(9): 1198 doi: 10.1158/1055-9965.EPI-23-0309
|
| 15 |
Xin Chen, Tailang Yin, Baozhen Zhang, Beini Sun, Jie Chen, Tianxia Xiao, Baobei Wang, Mengxia Li, Jing Yang, Xiujun Fan. Inhibitory effects of brusatol delivered using glycosaminoglycan‑placental chondroitin sulfate A‑modified nanoparticles on the proliferation, migration and invasion of cancer cells. International Journal of Molecular Medicine 2020; 46(2): 817 doi: 10.3892/ijmm.2020.4627
|
| 16 |
Qing Yuan, Song‐Quan Wang, Guang‐Tao Zhang, Jie He, Zhi‐Dan Liu, Ming‐Rong Wang, Hong‐Qing Cai, Jing‐Hai Wan. Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma. Immunity, Inflammation and Disease 2021; 9(4): 1618 doi: 10.1002/iid3.515
|
| 17 |
Yanxia Jin, Weidong Wang, Qiyun Wang, Yueyang Zhang, Kashif Rafiq Zahid, Umar Raza, Yongsheng Gong. Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02572-4
|
| 18 |
Montserrat Lara-Velazquez, Natanael Zarco, Anna Carrano, Jordan Phillipps, Emily S Norton, Paula Schiapparelli, Rawan Al-kharboosh, Jordina Rincon-Torroella, Stephanie Jeanneret, Teresa Corona, Jose Segovia, Mark E Jentoft, Kaisorn L Chaichana, Yan W Asmann, Alfredo Quiñones-Hinojosa, Hugo Guerrero-Cazares. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma. Neuro-Oncology 2021; 23(4): 599 doi: 10.1093/neuonc/noaa264
|
| 19 |
Hao Zhang, Lugen Zuo, Jing Li, Zhijun Geng, Sitang Ge, Xue Song, Yueyue Wang, Xiaofeng Zhang, Lian Wang, Tianhao Zhao, Min Deng, Damin Chai, Qiusheng Wang, Zi Yang, Quanli Liu, Quanwei Qiu, Xuxu He, Yiqun Yang, Yuanyuan Ge, Rong Wu, Lin Zheng, Jianjun Li, Runkai Chen, Jialiang Sun, Jianguo Hu. Construction of a fecal immune-related protein-based biomarker panel for colorectal cancer diagnosis: a multicenter study. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1126217
|